|
Market Closed -
London S.E.
09:07:00 2026-08-12 EDT
|
5-day change | 1st Jan Change | ||
| 0.1525 GBX | -4.69% |
|
-7.58% | -54.48% |
| 08-10 | ValiRx subsidiary Cytolytix nears "significant" European patent win | AN |
| 08-10 | ValiRx Unit Receives Intention to Grant European Patent for Anti-Cancer Peptide | MT |
| Market Cap | 2.11M 2.85M 2.47M 2.32M 3.98M 272M 4.04M 27.15M 10.64M 136M 10.72M 10.48M 455M | P/E 2024 |
-0.53x | P/E 2025 | -0.62x |
|---|---|---|---|---|---|
| Enterprise Value | 1.32M 1.79M 1.55M 1.45M 2.49M 170M 2.53M 16.99M 6.66M 85.28M 6.71M 6.56M 284M | EV / Sales 2024 |
27,264,249x | EV / Sales 2025 | 54,121,446x |
| Free-Float |
93.4% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -4.69% | ||
| 1 week | -7.58% | ||
| Current month | +1.67% | ||
| 1 month | +5.17% | ||
| 3 months | -45.54% | ||
| 6 months | -54.48% | ||
| Current year | -54.48% |
| 1 week | 0.15 |  | 0.18 |
| 1 month | 0.14 | | 0.18 |
| Current year | 0.13 | | 0.48 |
| 1 year | 0.13 | | 0.85 |
| 3 years | 0.13 | | 15 |
| 5 years | 0.13 | | 65 |
| 10 years | 0.13 | | 1,436.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Eccleston
CEO | Chief Executive Officer | 55 | 2024-08-11 |
Gerald Desler
DFI | Director of Finance/CFO | 81 | - |
Michelle Barnard
CTO | Chief Tech/Sci/R&D Officer | - | 2025-03-26 |
| Director | Title | Age | Since |
|---|---|---|---|
Gerald Desler
BRD | Director/Board Member | 81 | 2006-08-31 |
| Chairman | 60 | 2024-07-24 | |
Mark Eccleston
BRD | Director/Board Member | 55 | 2024-08-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/18/22 | Free | Director | 75,000 | 0.0832% | ||
| 10/18/22 | Free | Director | 75,000 | 0.0832% | ||
| 7/7/22 | Buy | Director | 100,000 | 0.1537% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.69% | -7.58% | -70.95% | -97.74% | 2.85M | |
| -0.73% | +12.52% | +74.33% | +102.34% | 70.51B | |
| +1.60% | +1.66% | +37.76% | +66.48% | 54.05B | |
| +1.17% | +35.98% | +10.36% | +503.79% | 28.95B | |
| -0.61% | +12.95% | +53.77% | +5.42% | 24.05B | |
| +0.49% | +1.20% | -15.95% | -13.17% | 23.31B | |
| -1.37% | +18.52% | +255.24% | +464.53% | 18.67B | |
| +2.21% | +7.66% | +47.18% | -19.64% | 18.37B | |
| 0.00% | +9.69% | +31.01% | +584.59% | 16.1B | |
| +0.10% | -9.26% | +35.57% | +139.19% | 12.72B | |
| Average | -0.18% | +8.96% | +45.83% | +173.58% | 26.67B | |
| Weighted average by Cap. | +0.31% | +10.12% | +56.56% | +167.63% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.05 0.07 0.06 0.05 0.09 6.41 0.1 0.64 0.25 3.21 0.25 0.25 10.71 | 0.03 0.04 0.04 0.03 0.06 4.04 0.06 0.4 0.16 2.02 0.16 0.16 6.75 |
| Net income | -1.92M -2.59M -2.24M -2.1M -3.6M -247M -3.67M -24.62M -9.65M -124M -9.72M -9.51M -412M | -2.23M -3.02M -2.61M -2.45M -4.2M -288M -4.27M -28.69M -11.24M -144M -11.32M -11.08M -480M |
| Net Debt | -1.54M -2.09M -1.81M -1.69M -2.91M -199M -2.95M -19.84M -7.77M -99.58M -7.83M -7.66M -332M | -790K -1.07M -925K -866K -1.49M -102M -1.51M -10.15M -3.98M -50.96M -4.01M -3.92M -170M |
Employees
11
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-12 | GBX 0.1525 | -4.69% | 3,690,412 |
| 26-08-11 | GBX 0.1600 | 0.00% | 2,022,292 |
| 26-08-10 | GBX 0.1600 | 0.00% | 19,753,165 |
| 26-08-07 | GBX 0.1600 | 0.00% | 1,020,672 |
| 26-08-06 | GBX 0.1600 | -3.03% | 19,786,728 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VAL Stock
Select your edition
All financial news and data tailored to specific country editions
